Tag Archives: Hyperthermia

Medicine Wellness Health

Dr. Hüseyin Sahinbas: New President of German Hyperthermia Society

Shanghai 2018 – Successful DGHT-eV expansion in China

Dr. Hüseyin Sahinbas: New President of German Hyperthermia Society

Dr. Sahibas present DGHT-eV

With Dr. Hüseyin Sahinbas, whose areas of specialty include hyperthermia, the German Hyperthermia Society, or DGHT-eV for short ( www.dght-ev.de), has elected a new president with particularly ambitious goals. One of his first actions in office involved setting up an academic exchange with colleagues in China and entering into a cooperation agreement with Shanghai“s Shulan Hospital. Both parties expect a creative and intensive clinical and scientific exchange in this context, in order to „further expand the quality and application of hyperthermia,“ according to Dr. Quing Xu, Director of the Tongji University Cancer Center. In addition to further scientific studies, this work will include defining and implementing guidelines for performing hyperthermia treatments with regard to individual entities. The objective of this step is to further establish the relevance of hyperthermia in conventional school medicine and to boost its acceptance. „We not only want to expand our international contacts, but also want to foster the cooperation of national associations,“ said Dr. Sahinbas, who outlined his goals as DGHT-eV President as follows:

– Build bridges between all associations dedicated to complementary (oncological) and conventional fields
– Build bridges between decision-makers in politics and medicine
– Build bridges between scientific research and colleagues working „in the trenches“
– Build bridges between doctors and affected patients seeking help
– Build bridges between science, patients and the media

„Hyperthermia is already supported by detailed studies in many areas and now has to make the leap to becoming accepted by insurance systems,“ says Dr. Sahinbas, adding, „This will be one of my core tasks as President. I will largely act as a link between many associations and colleagues, I see myself as a bridge builder for politics, science, but also for commercial institutions in medicine and insurance.“ True to his motto „It takes a vision to have a current plan,“ DGHT-eV will reposition itself within this framework to provide more active support for colleagues and to convince other physicians of the benefits of this therapy form. In order to achieve this in the near future, intensive talks are currently underway, for example at the Berlin Charite Hospital, to create a „hyperthermia specialist“ training course. „Clear guidelines and specialist training will make hyperthermia significantly more attractive for junior colleagues, and we hope to generate broad interest among young doctors. I particularly look forward to the task of communicating knowledge and experience in the treatment of cancer patients.
That makes my position as president of DGHT-eV very gratifying,“ says Dr. Sahinbas, whose long-term objectives include establishing an independent professorship for hyperthermia.

Dr. Hüseyin Sahinbas – President DGHT-eV

Bei Krebsleiden und chronischen Krankheiten ist die Hyperthermie mittlerweile mehr als nur ein Hoffnungsschimmer zur Prognoseverbesserung. Denn Hyperthermie kann Leben retten, verlängern und erheblich verbessern.

Das ist das Ziel der DGHT-eV

Company-Contact
DGHT-eV
Hüseyin Sahinbas
Gutenbergstr. 8
26135 Oldenburg
Phone: +49 441 – 936 54 58 – 6
E-Mail: info@dght-ev.de
Url: http://www.dght-ev.de

Press
DGHT-e.V.
Hüseyin Sahinbas
Gutenbergstr. 8
26135 Oldenburg
Phone: 0441 – 936 54 58 – 6
E-Mail: info@dght-ev.de
Url: https://www.dght-ev.de/home

Medicine Wellness Health

Full speed ahead – New Celsius42

The relaunch of Celsius42 GmbH is just a few days away

Full speed ahead - New Celsius42

Eschweiler 01.05.2018 – after 4 months and many hours of work by our creative team, we look forward to publishing our new company website in the near future.

„This innovation represents a true milestone for the development of Celsius42,“ says Christian Hartmann, the company“s new CEO. „In addition to the remake of our corporate identity, there are many ongoing activities associated with our product range,“ he adds. „We are currently working on our vision up to the year 2025. Our company will present many innovations and product enhancements at the MEDICA tradeshow in Düsseldorf this year and over the course of the coming years.“

Parallel to product and market development, the company“s priorities for the coming months and years naturally also include global expansion. Moreover, technical and scientific cooperation will be at the core of this growth strategy.

We invite you to visit us at ESHO in Berlin from May 16-19 to learn more about our innovations in direct conversations. We look forward to your visit. Our communication channels will keep you updated about the further activities of our company.

Your Celsius42 Team

Who we are.

The people working at Celsius42 have one shared goal – to be united in the fight against cancer. To pool knowledge. To leverage partners and resources. To explore increasingly intelligent pathways in medical technology to finally win the fight. Medicine has fought this battle for a long time. A battle against a clever opponent: cancer. Hyperthermia is the active principle of Celsius42 products. Targeted
thermal energy that causes stress in cancer cells. It has many positive effects in chemotherapy or radiation therapy, but also strengthens the immune system.

The people at Celsius42 know that they are on
the right track. Their tenacity, energy and human experience make them a tight-knit team. With a single mission: to develop innovative hyperthermia products that help to fight cancer gently but effectively.

That is Celsius42. That is TCS – Tumor Cell Solution.

Contact
Celsius42 GmbH
Christian Hartmann
Hermann-Hollerith-Straße 11
52249 Eschweiler
Phone: +49 2403 7829 230
E-Mail: info@celsius42.de
Url: http://www.celsius42.de